| Primary information |
|---|
| PRRID | PRRID_0434 |
| Ligand Name | Cinnamaldehyde |
| Source | China Medicine (Group) Shanghai Chemical Reagent(others) |
| Sequence of ligand | C1=CC=C(C=C1)C=CC=O |
| Length | NA |
| Type | Drug |
| Occurence | Synthetic |
| Role of Ligand | It inhibits the NF- |
| Name of receptor | Toll-like receptor 4 (TLR4) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | coxsackievirus B3 (CVB3)-induced viral myocarditis (VMC) |
| Localization | Heart |
| Domain | Leucine-rich Repeat (LRR) Domain |
| Sequence of Receptor | NA |
| Swiss prot ID | NA |
| Length Of Receptor | NA |
| Function | It has antiviral effects on VMC through its metabolite, cinnamic acid. |
| Assay used | NA |
| PMID | 20460981 |
| Year of Publication | 2010 |
| Pubchem assay | NA |
| Primary information |
|---|
| PRRID | PRRID_0434 |
| Ligand Name | Cinnamaldehyde |
| Source | China Medicine (Group) Shanghai Chemical Reagent(others) |
| Sequence of ligand | C1=CC=C(C=C1)C=CC=O |
| Length | NA |
| Type | Drug |
| Occurence | Synthetic |
| Role of Ligand | It inhibits the NF- |
| Name of receptor | Toll-like receptor 4 (TLR4) |
| Type of receptor | Toll-like receptor (TLR) |
| Source | coxsackievirus B3 (CVB3)-induced viral myocarditis (VMC) |
| Localization | Heart |
| Domain | Leucine-rich Repeat (LRR) Domain |
| Sequence of Receptor | NA |
| Swiss prot ID | NA |
| Length Of Receptor | NA |
| Function | It has antiviral effects on VMC through its metabolite, cinnamic acid. |
| Assay used | NA |
| PMID | 20460981 |
| Year of Publication | 2010 |
| Pubchem assay | NA |